The Role of Lead and Cadmium in Gynecological Malignancies Original paper
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read MoreI am a biochemist with a deep curiosity for the human microbiome and how it shapes human health, and I enjoy making microbiome science more accessible through research and writing. With 2 years experience in microbiome research, I have curated microbiome studies, analyzed microbial signatures, and now focus on interventions as a Microbiome Signatures and Interventions Research Coordinator.
-
Women’s Health
Women’s Health
Women’s health, a vital aspect of medical science, encompasses various conditions unique to women’s physiological makeup. Historically, women were often excluded from clinical research, leading to a gap in understanding the intricacies of women’s health needs. However, recent advancements have highlighted the significant role that the microbiome plays in these conditions, offering new insights and potential therapies. MicrobiomeSignatures.com is at the forefront of exploring the microbiome signature of each of these conditions to unravel the etiology of these diseases and develop targeted microbiome therapies.
-
Metals
Metals
Heavy metals play a significant and multifaceted role in the pathogenicity of microbial species.
-
Ovarian Cancer
Ovarian Cancer
Ovarian cancer is one of the most lethal cancers affecting women worldwide. Known for its "silent" progression, this disease often goes undetected until it reaches advanced stages, making early diagnosis crucial for improving survival outcomes. With a variety of subtypes, ovarian cancer presents unique challenges in both treatment and prevention. Recent advancements in research are shining a light on the importance of the microbiome, particularly how microbial imbalances in the gut and vaginal microbiota can influence cancer progression. Repurposed drugs such as metformin and innovative interventions like probiotics, microbiota transplantation, and intratumoral microbiota therapies offer promising new avenues for improving ovarian cancer treatment.
-
Breast Cancer
Breast Cancer
Traditionally linked to genetic predispositions and environmental exposures, emerging evidence highlights the microbiome as a critical and underappreciated factor influencing breast cancer progression, immune response, and treatment outcomes.
-
Divine Aleru
Read More
Researched by:
-
Divine Aleru
ID
Divine Aleru
Read More
Microbiome Signatures identifies and validates condition-specific microbiome shifts and interventions to accelerate clinical translation. Our multidisciplinary team supports clinicians, researchers, and innovators in turning microbiome science into actionable medicine.
Divine Aleru
What was studied?
The paper investigates the impact of two toxic heavy metals, lead (Pb) and cadmium (Cd), on the development of gynecological cancers such as ovarian, endometrial, and cervical cancers. The authors explore how these metals contribute to cancer development, particularly through mechanisms like oxidative stress, DNA damage, and their ability to mimic estrogen. This review highlights the potential of Pb and Cd as biomarkers for cancer risk and progression, emphasizing their roles in the oncogenesis of gynecological malignancies.
Who was studied?
The study centers around women exposed to Pb and Cd, particularly those with gynecological cancers. It examines clinical and experimental research linking elevated metal levels to cancer occurrence, focusing on ovarian, cervical, and endometrial cancers. The research delves into the biological changes these metals cause, including hormonal disruption, oxidative stress, and DNA damage, all of which are associated with cancer development.
Most important findings
The study identifies the carcinogenic properties of Pb and Cd, showing that both metals function as metalloestrogens, activating estrogen receptors and mimicking estrogen’s effects. This mechanism contributes to hormone-dependent cancers like ovarian, endometrial, and cervical cancers. Elevated levels of Pb and Cd were found in neoplastic tissues of these cancers, establishing a clear connection between their presence and increased cancer risk. These metals were also found to disrupt oxidative stress regulation, leading to cellular damage. Pb has been linked to increased cancer risks, particularly breast cancer, while Cd similarly affects estrogen receptors, promoting hormone-related cancers. The study also points to the possibility of using Pb and Cd as biomarkers for early detection and progression monitoring of gynecological cancers.
Key implications
This research underscores the importance of reducing environmental and occupational exposure to Pb and Cd, which are modifiable risk factors for gynecological cancers. Identifying these metals as potential biomarkers provides a valuable tool for early detection and diagnosis, offering a new avenue for cancer risk assessment. Reducing exposure to these metals is essential to mitigate cancer risk, and further studies are needed to understand their full role in cancer development.
Ovarian Cancer
Ovarian cancer is one of the most lethal cancers affecting women worldwide. Known for its "silent" progression, this disease often goes undetected until it reaches advanced stages, making early diagnosis crucial for improving survival outcomes. With a variety of subtypes, ovarian cancer presents unique challenges in both treatment and prevention. Recent advancements in research are shining a light on the importance of the microbiome, particularly how microbial imbalances in the gut and vaginal microbiota can influence cancer progression. Repurposed drugs such as metformin and innovative interventions like probiotics, microbiota transplantation, and intratumoral microbiota therapies offer promising new avenues for improving ovarian cancer treatment.
Metalloestrogens
Metalloestrogens are metals that activate the estrogen receptor in the absence of estradiol.